Dr. Krause has worked on numerous high-profile matters, many of which involved blockbuster drugs. Most recently, he helped lead teams for GlaxoSmithKline affiliate ViiV Healthcare and Shionogi & Co. that obtained a $1.25 billion settlement, plus royalties, in a global pharmaceutical drug lawsuit against Gilead Sciences; and for Avanos Medical that obtained a very favorable settlement against Medtronic involving a medical device. He has also represented clients in matters related to the cancer immunotherapy Keytruda®, the Nobel Prize winning method PCR, and numerous Hatch-Waxman litigations, including cases related to treatments for arthritis (Arthrotec®), high blood pressure (Bystolic®), pain (Nuycnta®), blood clots (Xarelto®), asthma (Xopenex HFA®), high cholesterol (Zetia®; Vytorin®), and metastatic prostate cancer (Zytiga®).
Dr. Krause is active in legal organizations and has been recognized by LMG Life Sciences as a Hatch-Waxman Patent Litigation “Star,” by Managing Intellectual Property as an “IP Star,” featured in the IAM Patent 1000, and in The Legal 500.
Prior Experience
- Partner, Sidley Austin LLP, New York, 2008-2018
- Counsel, Sidley Austin LLP, New York, 2005-2008
- Associate, Orrick, Herrington & Sutcliffe LLP, New York, 2002-2005
- Associate, Pennie & Edmonds LLP, New York, 1997-2002
Courts
- United States Supreme Court
- United States Court of Appeals for the Federal Circuit
- United States District Court for the Eastern District of New York
- United States District Court for the Southern District of New York
- United States District Court for the Western District of New York
Memberships & Affiliations
- American Bar Association
- New York Intellectual Property Law Association
- American Intellectual Property Law Association
- New Jersey Intellectual Property Law Association